Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Apr 2026, Jun 2026 and Jul 2026.
- Largest single sale: $387K (3,389 shares) of Kymera Therapeutics, Inc. on Jul 1, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | Apr 9, 2025 | Jul 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 1, 2026, Kymera Therapeutics, Inc.: sold 3,389 shares for $387K, under a disclosed plan. 1 filing: 1
- Jun 25, 2026, Kymera Therapeutics, Inc.: sold 5,000 shares for $570K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Jun 22, 2026, Kymera Therapeutics, Inc.: sold 2,500 shares for $248K, under a disclosed plan; 2,500 shares acquired by exercising options. 1 filing: 1
- Apr 14, 2026, Kymera Therapeutics, Inc.: sold 1,347 shares for $121K, under a disclosed plan. 1 filing: 1
- Apr 10, 2026, Kymera Therapeutics, Inc.: sold 2,000 shares for $175K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.